Smoking and risk of colorectal cancer according to KRAS and BRAF mutation status in a Japanese prospective Study
- PMID: 37352389
- DOI: 10.1093/carcin/bgad046
Smoking and risk of colorectal cancer according to KRAS and BRAF mutation status in a Japanese prospective Study
Abstract
Although smoking is a major modifiable risk factor for many types of cancer, evidence for colorectal cancer is equivocal in Asian populations. Recent Western studies have proposed that the association between smoking and colorectal cancer is restricted to specific tumor molecular subtypes. However, no studies have evaluated the association according to tumor molecular subtypes in Asian populations. In a Japanese prospective population-based cohort study of 18 773 participants, we collected tumor tissues from incident colorectal cancer cases and evaluated KRAS (Kirsten rat sarcoma viral oncogene homolog) and BRAF (v-raf murine sarcoma viral oncogene homolog B) mutation status using target sequencing. Multivariable-adjusted Cox proportional hazard model was used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for associations of smoking with the risk of overall colorectal cancer and its subtypes defined by KRAS and BRAF mutation status. Among 339 cases, KRAS and BRAF mutations were identified in 164 (48.4%) and 16 (4.7%) cases, respectively. The multivariable-adjusted HR for ever smoking compared with never smoking was 1.24 [95% CI: 0.93-1.66], 1.75 [1.14-2.68], 0.87 [0.59-1.29], 1.24 [0.93-1.67] and 1.22 [0.38-3.93] for overall, KRAS wild-type, KRAS-mutated, BRAF wild-type and BRAF-mutated colorectal cancer, respectively. The statistically significant heterogeneity was indicated between KRAS mutation status (Pheterogeneity = 0.01) but not between BRAF mutation status. This study is the first to demonstrate that smokers have an approximately 2-fold higher risk of KRAS wild-type colorectal cancer than never smokers in an Asian population. Our findings support that smoking is a risk factor for colorectal cancer, especially for its subtype without KRAS mutations, in Asian populations.
© The Author(s) 2023. Published by Oxford University Press. All rights reserved. For Permissions, please email: [email protected].
Similar articles
-
Cigarette smoking and colorectal cancer risk by molecularly defined subtypes.J Natl Cancer Inst. 2010 Jul 21;102(14):1012-22. doi: 10.1093/jnci/djq201. Epub 2010 Jun 29. J Natl Cancer Inst. 2010. PMID: 20587792 Free PMC article.
-
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.Clin Colorectal Cancer. 2017 Sep;16(3):e153-e163. doi: 10.1016/j.clcc.2017.01.004. Epub 2017 Jan 25. Clin Colorectal Cancer. 2017. PMID: 28216246 Review.
-
Associations of anthropometric factors with KRAS and BRAF mutation status of primary colorectal cancer in men and women: a cohort study.PLoS One. 2014 Jun 11;9(2):e98964. doi: 10.1371/journal.pone.0098964. eCollection 2014. PLoS One. 2014. PMID: 24918610 Free PMC article.
-
Metabolic factors and the risk of colorectal cancer by KRAS and BRAF mutation status.Int J Cancer. 2019 Jul 15;145(2):327-337. doi: 10.1002/ijc.32104. Epub 2019 Jan 24. Int J Cancer. 2019. PMID: 30613980
-
Immunohistochemistry with Anti-BRAF V600E (VE1) Mouse Monoclonal Antibody is a Sensitive Method for Detection of the BRAF V600E Mutation in Colon Cancer: Evaluation of 120 Cases with and without KRAS Mutation and Literature Review.Pathol Oncol Res. 2019 Jan;25(1):349-359. doi: 10.1007/s12253-017-0344-x. Epub 2017 Nov 10. Pathol Oncol Res. 2019. PMID: 29127628 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous